chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Loud ringing in hears with muffled hearing and nausea began on approximately 2/25 (best estimate). Hearing issues progressed over the next few days to become almost constant and extremely unpleasant. Nausea became severe and turned to uncontrollable vomiting with extreme headache on Monday 2/29 and I went to Urgent care. Treatment improved headache, but did not provide complete relief. Hearing symptoms remained. Returned to Urgent care 3/1. Provided with IV steroids. Headache finally resolved. Hearing issue and mild nausea remained. By the time I obtained my second COVID vaccine (3/11) symptoms had improved by about 50%. However, after receiving second dose, they became worse again. It was then I thought of a possible connection to the vaccine. None of the doctors I had seen had brought it up and it hadn't occurred to me either. Good news for me: It has now been almost a month since my second dose and my symptoms have finally (just in the last few days) improved markedly. I still have hearing issues, mostly now just in the evenings. I am hoping this resolves soon. I am seeing an ENT and having a hearing test next week to see if there has been any damage, etc.   Given MRI. Results normal. Referred to Neurologist and ENT.
I have an IUD and have not had a period in several years. I had menstrual bleeding after the second shot.
Pt recv vax on 8/26/98; on 8/28/98 pt exp 10X7 firm erythamatous patch overlying injection site; tx=Benadryl 25mg PO TID prn.
I had the shot at 8:30 am. My arm became swollen and red by 1:00 pm. By 1:30 I was shaking violently. It lasted about 30 min. I went to bed and put on extra covers and drank hot tea. I also put ice pack on arm after I stopped shaking. My arm remained swollen for two days. No problems after that.
Headache Tues 8/14/12 & fever. 5:30 Seizure Wed (went uncon.) 8/15/12 was ambulance / air to hospital then to hospital in another city by air.
very tired (fatigue); Headache; This is a spontaneous report from a contactable consumer (patient). This 69-year old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EL9262) via an unspecified route of administration in the left deltoid on an unspecified date (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (lot number EL3246) in Jan2021 (at the age of 69-years-old) for COVID-19 immunisation and experience pain in arm and vaccination site pain; flu shot on an unknown date for immunisation and experienced pain; and shingles shot on an unknown date for immunisation and experienced pain. The patient reported that on the third day after the second injection she was very tired (fatigue) for a short period of time. A few days after, she experienced headache for a short period of time. The clinical outcomes of very tired (fatigue) and headache were unknown.
injection site arm left arm was hurting her; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site arm left arm was hurting her) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (injection site arm left arm was hurting her). At the time of the report, VACCINATION SITE PAIN (injection site arm left arm was hurting her) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not provided by the reporter. Treatment of events was not reported.    This case was linked to MOD-2021-069636 (Patient Link).
First dose 2-Mar-2021 , Second dose 9-Apr-2021; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose 2-Mar-2021 , Second dose 9-Apr-2021) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 006M20A) for COVID-19 vaccination.     It was reported that the patient did not have any allergies to medication, food and other products, and also the patient did not have any acute illness at the time of vaccination and up to one month before. The patient had never been diagnosed with/ tested positive for COVID-19. The patient had no chronic or long-standing health conditions.    On 02-Mar-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 09-Apr-2021 at 1:23 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 09-Apr-2021 at 1:23 PM, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose 2-Mar-2021 , Second dose 9-Apr-2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose 2-Mar-2021 , Second dose 9-Apr-2021) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had no concomitant medications taken at time of vaccination and or at the time of the adverse event.  It was reported that, the patient did not have any adverse event included signs symptoms, clinical course and or treatment with dates/timelines. Patient did not experience, any symptoms during the temperature excursion. The event did not cause patient to seek medical care. The patient did not experience similar events in the past. No information on treatment medications was reported.   This case was linked to MOD-2022-503551 (Patient Link).
no additional adverse events reported; Proquad was administered improperly stored; This spontaneous report was received from a medical assistant and refers to a 4-year-old patient of unknown gender. No information regarding patient's pertinent medical history, drug reactions, allergies and concomitant medications.   On 23-SEP-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (albumin status: recombinant Human albumin (rHA))(PROQUAD) at a dose of 0.5 ml, lot # T034614, has been confirmed to be a valid, expiration date 10-APR-2021 for prophylaxis (dose #, route and anatomical location were not provided). The temperature excursion was as follows: 6 degrees Fahrenheit (F) to 14 F (8.5 degrees F) for 18 minutes and 6 degrees F to 14 degrees F (11.9 degrees F) for 1 hour. There were no previous excursions reported. No adverse events were reported.
Bilateral muscular (?) neck pain, most pronounced when I move my head or neck.; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received first dose of BNT16B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207), solution for injection, via an unspecified route of administration in the left arm on 17Mar2021 at 11:00 AM (at the age 69-year-old) as first single dose for COVID-19 immunisation. The patient had no medical history. The patient had no allergies to any medication, food or other products. Concomitant medication included vit D3 (MANUFACTURER UNKNOWN), cranberry caps (MANUFACTURER UNKNOWN), vit C (MANUFACTURER UNKNOWN), aspirin (MANUFACTURER UNKNOWN), benad (MANUFACTURER UNKNOWN); all for an unknown indication from unknown dates, unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021, at 11:30, the patient experienced bilateral muscular neck pain, most pronounced when the head or neck was moved. The patient did not receive any treatment for the event. The clinical outcome of bilateral muscular neck pain was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
For after being vaccinated against Covid-19/Patient got tested for covid on 09Jul2021/he was positive for covid; For after being vaccinated against Covid-19; This is a spontaneous report from a contactable consumer. This contactable consumer (patient's wife) reported for a 78-year-old male patient.   A 78-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot Number: ER8736; Expiration Date: 31Jul2021), dose 2 via an unspecified route of administration, administered in Arm on 30Apr2021 10:30 (age at the time of vaccination was 78-year-old) as single dose for COVID-19 immunization. Medical history included COVID-19 from Dec2020 to Jan2021 (Patient had covid in late Dec 2020 to early Jan 2021). There were no concomitant medications. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0151; Expiration Date: on an unspecified date in Jul2021), dose 1 via an unspecified route of administration, administered in Arm on 09Apr2021 10:30 as single dose for COVID-19 immunization. The reporter reported that she and her husband both had COVID in late Dec2020 to early Jan2021. she stated she and her husband both received both doses of the Pfizer covid vaccine. Reporter's husband is the patient. Patient was now tested positive for COVID again. Because it was a mild case of COVID, the CDC does not care. Reporter was very aggravated because they had their grandkids over that past weekend and exposed them to COVID. Reporter and patient thought they were safe to have family over because they received the COVID vaccine. Now patient has tested positive for COVID. The patient got tested for COVID on 09Jul2021. The hospital called yesterday, 11Jul2021, and told patient he was positive for COVID and cancelled his surgery. The patient was supposed to have a total knee replacement on 12Jul2021. Prior to patient's knee replacement, patient had got a big check-up. The doctors did an EKG, and everything was fine. The doctor told patient he was in the best health out of anyone his age. The reporter stated she was going to go get tested for COVID. The patient underwent lab tests and procedures which included electrocardiogram: fine on 09Jul2021, sars-cov-2 test: positive on 09Jul2021. Outcome of the events was reported as unknown.   Follow-up attempts are needed. Further information is requested.
10:10 Pt. c/o feeling hot, symptoms progressed to heaviness feeling in chest; 10:25 LOC few seconds, revived 10:30 LOC x 1 min, revived 10:35 LOC x 1 minute, revived, 10:40 LOC - utilized ammonia inhalant to revive. oxygen @ 64 min. EMS notified. B/p 150/100. 10:50 EMS arrived transported to local ER B/p 150/110. Approx. 2 1/2 hrs later, student returned to school with parent. "Feeling ok." ER discharge dX - anxiety/vasovagal reaction.
Pt reported needing first dose of COVID vaccine, but had apparently forgotten that she had previously received a dose of Pfizer and was due for a second Pfizer shot.
rash/ Rash, spread from site of injection all the way to the face; rash/ Rash, spread from site of injection all the way to the face; This case was reported by a other health professional via call center representative and described the occurrence of injection site rash in a 5-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2020-2021 season) (batch number 7P5BE, expiry date 30th June 2021) for prophylaxis.   On 27th October 2020, the patient received the 1st dose of Fluarix Quadrivalent 2020-2021 season (intramuscular). On 27th October 2020, 1 hr after receiving Fluarix Quadrivalent 2020-2021 season, the patient experienced injection site rash and rash. On an unknown date, the outcome of the injection site rash and rash were not recovered/not resolved.   It was unknown if the reporter considered the injection site rash and rash to be related to Fluarix Quadrivalent 2020-2021 season.  Additional details were provided as follows: The age at vaccination was not reported but it could be 4 years or 5 years. The reporter called to request information on the presence of milk protein in the Fluarix vaccine since a patient developed a rash after being given the Fluarix vaccine.  The vaccine was given on 27th October 2020 in right thigh and rash started same day. It went from the site of injection all the way to the face, worsening by day of report 28th October 2020. The reporter confirmed that there was no fever or runny nose, no other symptom aside from the rash. The reporter consented to follow up.
Left deltoid red, hard and swollen. Began to turn red 4 to 5 hours after injection. Was seen in office arm swollen and red from shoulder to elbow. Place on Keflex 250 mg PO for 10 days. Also given Clarinex.
does not eat anything; dehydrated; Fever; headache; vomits; This spontaneous case was reported by a physician and describes the occurrence of FEEDING DISORDER (does not eat anything), DEHYDRATION (dehydrated), PYREXIA (Fever), HEADACHE (headache) and VOMITING (vomits) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 17-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced FEEDING DISORDER (does not eat anything), DEHYDRATION (dehydrated), PYREXIA (Fever), HEADACHE (headache) and VOMITING (vomits). At the time of the report, FEEDING DISORDER (does not eat anything), DEHYDRATION (dehydrated), PYREXIA (Fever), HEADACHE (headache) and VOMITING (vomits) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included medication for diabetes.  No treatment information was provided.
2 days post vaccination, I developed what appeared to be a rash on the back of left leg behind knee (approx 5pm). Next evening the rash spread and by day 5 the rash spread more.  Redness, tenderness, stinging & burning sensation / pustules I contacted PCP due to worsening spread of rash and informed I had shingles. I provided pictures of the rash from day 2, 3 and 5. PCP consulted Infectious Disease colleague who confirmed shingles. I was instructed to get Immunoglobulin G antibody testing, which I did, on 1/26/21. Currently awaiting lab results. Informed that I may need anti-viral and anti-biotic depending on lab results. There was NO illness, new medication, change in diet, soaps, perfumes or laundry detergents prior to 1st dose of COVID-19 vaccination.
Driving home from the vaccine I had double vision and a feeling like I was going up and down in an elevator. The next day I had the sore arm, aches and headache as expected. Sunday, started with carpal tunnel pain that extended from my left shoulder through my fingers as well as some vision issues where my eyes sort of had double vision again but I couldn?t blink it away for a minute. Monday morning I felt my right eye suddenly change vision where the one eye suddenly saw at a 45 degree angle.  My husband said my eye looked ok but I could clearly see 2 of him and couldn?t blink it away for a solid minute or so. Today my eyes are blurry and I?m dizzy. I reported this to my doctor yesterday to see if what was happening was vaccine related and she asked me to report it here.
Respiratory problems of congestion and had shortness of breath; Shortness of breath really badly for one day; This spontaneous case was reported by a consumer and describes the occurrence of RESPIRATORY TRACT CONGESTION (Respiratory problems of congestion and had shortness of breath) and DYSPNOEA (Shortness of breath really badly for one day) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history).    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced RESPIRATORY TRACT CONGESTION (Respiratory problems of congestion and had shortness of breath) and DYSPNOEA (Shortness of breath really badly for one day). At the time of the report, RESPIRATORY TRACT CONGESTION (Respiratory problems of congestion and had shortness of breath) and DYSPNOEA (Shortness of breath really badly for one day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Painful lymph node on left collar bone; Swollen lymph node on left collarbone; This is a spontaneous report from a contactable other healthcare professional, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 26Mar2021 at 09:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa (sulfonamide) allergy. The patient did not receive any medication within two weeks of the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 01Apr2021 at 09:00, approximately 6 days after the first dose, the patient experienced a very painful and swollen lymph node on left collarbone. The event did not result in a doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event very painful and swollen lymph node on left collarbone was resolving at the time of this report.  No follow-up attempts are needed; information about lot number cannot be obtained.
Pt recvd a series of 3 Hep B vax given 23JUN89, 20JUL89, 14DEC89 respectively; 1st & 2nd doses were w/?Heptavax;, 3rd dose was w/Engerix-B; did not have titers p/3rd dose but did develop Antibodies p/4th dose given 19NOV90;
This case was reported by a consumer via call center representative and described the occurrence of adverse event in an unspecified number of adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown. It was unknown if the reporter considered the adverse event to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not applicable for this report. The age group was not reported but was captured as adult as per vaccine indication. While caller was reporting side effects to 2nd dose of SHINGRIX, stated he heard a lot of people have experienced issues with the 2nd dose. No other information was provided.
Pt called with adverse event.  Swelling, rash, and pain all at injection site.  Described lump at site as about the size of an egg.  Pain was refractory to treatment with acetaminophen, morphine, and a "pain patch."
RN adminstered 1.0ML erroneously. The patient did not experience any adverse reactions.
Nausea, vomiting, diarrhea, severe body aches, chills, fatigue, headache, cough, difficulty taking a deep breath, extreme soreness at injection site (obviously)
9 x 10 reddened, firm, warm area around site of inj. - (anterior bicep area) 6-4-12. I spoke with mother. Stated the reaction is clear but lasted until 5/28 or 5/30/12.
I had the Afluria Quadrivalent flu vaccine (October 2016) caused me to have major reactions neurologically. Wanted to state this before I stated adverse events from Dose 3 of Pfizer. The moment after Dose 3 vaccine I started having numbness in right arm, and tingling. As time went on it continued to get more numb. I contacted my doctor and was advised to take B12. When I woke up on Saturday still felt a shooting pain down my right arm and experienced chills. On Sunday I didn't have minor shooting pain in right arm took Motrin. I woke up on Monday, had little problems and on Tuesday the shooting pain has started again.
big bruise on her face; had bad joint problems since my pfizer covid vaccine. It's hard to bend and move; had bad joint problems since my pfizer covid vaccine. It's hard to bend and move; Patient fell; This is a spontaneous report from a contactable consumer (patient's neighbour). A 75-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) (at the age of 75-year-old) as 1st dose, single dose, dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single dose for covid-19 immunisation. The patient medical history and concomitant medications included none. Family medical history relevant to events was unknown. The patient did not receive any other vaccines within four weeks prior to the vaccination. It was unknown if patient received additional vaccines administered on same date of the Pfizer suspect. On an unspecified date, the reporter stated that patient had joint pain since her Pfizer covid shot. The patient had bad joint problems since pfizer covid vaccine. It's hard to bend and move. The patient fell and was hospitalized. After patient fell down, she had to go to the hospital. The patient falling down, was part of the reason for patient's joint pain. Patient fell and could not get up, and they had to call 911. The reporter thinks it was Feb2021 whenever patient fell down in parking lot. After falling, patient had to go to the hospital. The reporter could not help patient move because of her own shoulder pain after receiving the Pfizer covid vaccine. Reporter explained that to patient, and patient stated she has had joint pain after the covid vaccine too, and that she still has joint pain ever since she fell. Reporter thinks patient fell about two months ago. Reporter does not know dates that patient received either dose of the covid vaccine. Reporter confirms that patient received both doses of the Pfizer covid vaccine. The reporter does not know if patient fell after the first dose, or second dose of the Pfizer covid vaccine. Reporter believes that patient was admitted to the hospital. The patient had a big bruise on her face. The reporter does not know dates of hospitalization. The patient told reporter that she fell and had to go to the hospital. Reporter knows that it was after patient got the covid vaccine. Reporter does not know if it was right after patient received the covid vaccine, or later. Events resulted in emergency room visit. The relevant tests included none. The outcome of the events was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021642670 Same reporter / drug, different patient;US-PFIZER INC-2021641551 Same reporter/ drug,different patient